Tekmira Claims Alnylam Stole Gene Therapy Secrets

Law360, New York (March 16, 2011, 8:38 PM EDT) -- Tekmira Pharmaceuticals Corp. is suing its collaborator Alnylam Pharmaceuticals Inc. in Massachusetts state court for allegedly misappropriating trade secrets and other confidential information related to gene-silencing therapeutics, and damages could amount to more than $1 billion, the company said Wednesday.

The British Columbia-based company lodged its suit in the Massachusetts Superior Court, claiming Alnylam exploited its confidential relationship as a collaborator with Tekmira by trying to pass off Tekmira’s proprietary lipid nanoparticle siRNA delivery technology as its own.

The suit asserts that Cambridge, Mass.-based Alnylam misused...
To view the full article, register now.